TEAM.NASDAQAtlassian CORP

Form 4: Atlassian CEO Michael Cannon-Brookes Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


Atlassian CEO Michael Cannon-Brookes executed multiple sales of Class A Common Stock on October 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Michael Cannon-Brookes, CEO and Co-Founder of Atlassian, reported the sale of Class A Common Stock on October 15, 2024.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on February 8, 2024.
  • The transactions involved multiple trades at varying prices, ranging from $190.45 to $195.18 per share.
  • A total of 7,948 shares were sold, resulting in a change in beneficial ownership.
  • The shares are held indirectly by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.
  • Following the reported transactions, Cannon-Brookes indirectly owns 421,244 shares through the trust.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to stock sales under a pre-arranged trading plan. It doesn't convey any particularly positive or negative sentiment about the company's performance or future prospects.

Industry Context

Insider sales are a common occurrence, especially when executed under pre-arranged trading plans like Rule 10b5-1. These plans allow insiders to sell shares at predetermined times and prices, avoiding accusations of trading on non-public information. The market typically views these sales in the context of the overall trading plan and the insider's remaining holdings.

Comparison to Industry Standards

  • Comparing Cannon-Brookes' transactions to other tech CEOs, similar sales under 10b5-1 plans are frequent.
  • For example, executives at companies like Microsoft and Amazon routinely use such plans to diversify their holdings.
  • The size of the sale (7,948 shares) is relatively small compared to the total holdings, suggesting it's part of a planned diversification strategy rather than a reaction to company performance.
  • The weighted average prices achieved are within a normal trading range for Atlassian's stock, indicating no unusual market impact.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholders due to the slight dilution of shares.
  • However, given the pre-arranged nature of the sale and the relatively small number of shares involved, the impact is likely to be minimal.

Key Dates

DateDescription
02/08/2024Date of adoption of Rule 10b5-1 trading plan
10/15/2024Date of stock sale transactions
10/16/2024Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.